Rite Aid up 22% premarket on Q3 beat; non-GAAP EPS guidance raised

Rite Aid (RAD) Q3 results: Revenues: $5,462.3M (+0.2%); Retail Pharmacy Segment: $3,909.9M (-1.7%); Pharmacy Services Segment: $1,613.1M (+5.7%).

Net Income: $52.3M; EPS: $0.98; non-GAAP Net Income: $29.1M (+98.0%); non-GAAP EPS: $0.54 (+92.9%); CF Ops: $423.7M (+20.7%).

FY 2020 guidance: Revenues: $21.5B-$21.9B (unch); net loss: ($174M)-(204M) from ($235M)-(275M); non-GAAP EPS: $0.13-$0.55 from $0.00-$0.56; non-GAAP EBITDA: $515M-$545M from $510M-$550M; Capex: ~$230M from ~$250M.

Shares are up 22% premarket.

https://seekingalpha.com/news/3527381-rite-aid-up-22-premarket-on-q3-beat-non-gaap-eps-guidance-raised